ZTS Q3 2025 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q3 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.4B+0.5% YoY

Gross Profit

$1.7B70.2% margin

Operating Income

$936M39.0% margin

Net Income

$721M30.0% margin

EPS (Diluted)

$1.63

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

$938M

Free Cash Flow

$805M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$15.2B

Total Liabilities

$9.8B

Stockholders' Equity

$5.4B

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.4B	$2.4B	+0.5%
Gross Profit	$1.7B	$1.7B	+2.0%
Operating Income	$936M	$920M	+1.7%
Net Income	$721M	$682M	+5.7%

Revenue Segments

Dogs and Cats

$1.6B68%

Cattle

$399M17%

Swine

$111M5%

Poultry

$106M5%

Fish

$78M3%

Horses

$66M3%

Geographic Segments

United States Segment

$1.3B56%

International Segment

$1.1B44%